ライフサイエンスコーパス: nebulizer

1 ) and two doses of UTP (20 and 100 mg in the nebulizer).

2 cted with analytes (M) generated in a heated nebulizer.

3 ad to be used instead of the helium-assisted nebulizer.

4 x application using an oscillating capillary nebulizer.

5 e extraction phase, 12 muL of xylene, to the nebulizer.

6 rog 4 times daily (n = 6), via an ultrasonic nebulizer.

7 ily aerosolized with a commercial compressor nebulizer.

8 for 2 mM matrix solutions with an ultrasonic nebulizer.

9 dose of Exosurf aerosolized by an ultrasonic nebulizer.

10 for both the helium-assisted and thermospray nebulizers.

11 ing had minimal or no contamination of their nebulizers.

12 ltophilia was isolated from 4 of 35 home-use nebulizers.

13 ative to solution analysis with conventional nebulizers.

14 es of 0.2-100 microg mL(-1) using one of the nebulizers.

15 by using commercially available radioaerosol nebulizers.

16 prototype for generation of aerosol using a nebulizer and collection using a cyclone collector was u

17 spectrometer equipped with a microconcentric nebulizer and membrane desolvator was used to provide hi

18 on in aqueous solution delivered through the nebulizer and the diluent air flow rate.

19 f the aerosol cone from the direct injection nebulizers and the nebulizer-spray chamber arrangement c

20 it with a laser ablation unit, a concentric nebulizer, and a droplet-on-demand system for sample int

21 n (FAPCI) source, consisting of a miniflame, nebulizer, and heated tube, was developed to ionize anal

22 The aerosol was generated in a Collison nebulizer, and the particles were dried in a diffusion d

23 positive pressure breathing assist devices, nebulizers, and oxygen compressors) was responsible for

24 s isolated from 3 of [corrected] 35 home-use nebulizers, and Stenotrophomonas maltophilia was isolate

25 nd ABLC were administered postoperatively by nebulizer at doses of 25 mg and 50 mg, respectively, whi

26 or precision as compared to the thermospray nebulizer at flow rates of up to 1.0 mL/min using isocra

27 HNO3 solution and aspirated directly to the nebulizer-burner system of a FAAS instrument using a flo

28 measurements of inhaled mass (percentage of nebulizer charge, mean +/- SEM) ranged from 5.7 +/- 0.5%

29 osol was administered through an Aerotech II nebulizer (CIS-US, Inc., Bedford, MA) mouthpiece.

30 s been implemented using a total consumption nebulizer coupled to inductively coupled plasma mass spe

31 demountable direct injection high-efficiency nebulizer (d-DIHEN), is successfully incorporated for th

32 The self-aspiration of the heated nebulizer delivers approximately 20 microL/min of the 3.

33 Nebulizer delivery of aerosolized aminoglycosides is eff

34 ly low-cost direct injection high-efficiency nebulizer (DIHEN) is introduced for argon inductively co

35 A direct-injection high-efficiency nebulizer (DIHEN) is used to couple a thin-layer electro

36 ices: (1) a direct injection high-efficiency nebulizer (DIHEN); (2) a large-bore DIHEN; and (3) a Mic

37 tems: (1) a direct injection high-efficiency nebulizer (DIHEN); (2) a large-bore DIHEN; and (3) a PFA

38 Compared to a direct injection nebulizer (DIN), the DIHEN was easier to operate.

39 than those reported for the direct injection nebulizer (DIN).

40 Nebulizer efficiency at a flow rate of 6 L/min was five

41 lacebo (n = 80) via an investigational eFlow nebulizer every 12 hours for 6 months.

42 esearch may be used to develop smart-tunable nebulizers, for example, by using the measured momentum

43 A nebulizer-free coaxial sheath-flow interface completes t

44 High RF power (1500 W), low nebulizer gas flow rates (0.25-0.35 L/min), and low solu

45 Heating the nebulizer gas in spray-only mode allows improved analyte

46 optimization of vaporization temperature and nebulizer gas pressure it was possible to significantly

47 llary blockage and optimally operates at low nebulizer gas pressures compared with the conventional D

48 rated at ambient conditions with nitrogen as nebulizer gas.

49 eir application to deposition studies of two nebulizer-generated aerosols (mass median diameter 1.5 a

50 as 2.5 mL/min, so a conventional thermospray nebulizer had to be used instead of the helium-assisted

51 A high efficiency nebulizer (HEN) coupled to a heated spray chamber and a

52 concentrations using LC/MS/MS with a heated nebulizer (HN) interface, instead of a TISP interface, i

53 ect using two different interfaces (a heated nebulizer, HN, and ion spray, ISP) under otherwise the s

54 o followed recommended instructions for good nebulizer hygienic practice and paid particular attentio

55 ntum as a feedback control for adjusting the nebulizer, i.e., its operating conditions, its critical

56 large bore-direct injection high efficiency nebulizer (IB-DIHEN) is introduced that is less prone to

57 of column separation to electrospray MS and nebulizer ICP MS.

58 ed cells were generated utilizing a Collison nebulizer in a whole-body Madison Chamber at different h

59 th an integrated stirring system, a Meinhard nebulizer in combination with a heated single-pass spray

60 e more advantageous than the microconcentric nebulizer in terms of minimizing memory effects and pote

61 ry from metered-dose inhalers (MDIs) and jet nebulizers in an in vitro model of mechanical ventilatio

62 increased aerosol delivery for both MDIs and nebulizers in the mechanically ventilated model by as mu

63 acerbations in the emergency department, but nebulizers may still have a role in home and inpatient a

64 anisole) jet, which is generated by a heated nebulizer microchip and directed toward the mass spectro

65 inhaled DLPC only, administered through the nebulizer mouthpiece.

66 5.08% (SD) of the initial drug placed in the nebulizer (neb-charge).

67 interface based on an oscillating capillary nebulizer (OCN) is described for direct deposition of el

68 escribes the use of an oscillating capillary nebulizer (OCN) to spray small droplets of matrix aeroso

69 two strains of B. cepacia recovered from the nebulizer of a third patient was also present in the spu

70 d sample, which is directly connected to the nebulizer of an ICP-MS instrument.

71 od uses a solvent jet generated by a coaxial nebulizer operated at ambient conditions with nitrogen a

72 Compared to the conventional thermospray nebulizer operated at solvent flow rate of 1 mL/min, the

73 free-flowing aerosol generated by a medical nebulizer or atomizer.

74 der of the neb-charge was sequestered in the nebulizer or exhaled.

75 and others was accounted for by spontaneous nebulizers (p = .001), metered dose inhalers (p = .01),

76 ged into an aerosol generated by a pneumatic nebulizer (PN) and introduced into an ICPMS.

77 ined with a conventional crossflow pneumatic nebulizer (PN), equipped with a Scott-type spray chamber

78 chamber set to drying gas flow of 6 mL/min, nebulizer pressure of 5 psi, and drying gas temperature

79 s (capillary voltage, vaporizer temperature, nebulizer pressure) were found to have effects on detect

80 rying gas flow rate, drying gas temperature, nebulizer pressure, and fragmentor voltage were investig

81 Although in the SIM mode ESI-MS parameters (nebulizer pressure, drying gas flow rate, drying gas tem

82 o of (+/-)BOH, two of the ESI-MS parameters (nebulizer pressure, sheath flow rate) were found to have

83 plumbing scheme and a self-aspirating heated nebulizer probe of a corona discharge atmospheric pressu

84 A helium-assisted nebulizer provided added stability with no loss in accur

85 The on-chip pneumatic nebulizer provided control of the flow of the electrospr

86 By incorporating a spray nebulizer sample deposition method to produce uniform sa

87 d from environmental specimens (i.e., from a nebulizer solution and a nebulizer tube).

88 are compared with an established technique, nebulizer SP-ICPMS.

89 from the direct injection nebulizers and the nebulizer-spray chamber arrangement consists of fast (>1

90 IHEN are superior to those of a conventional nebulizer-spray chamber combination, but precision is in

91 ees C evaporator temperature, 77.9 degrees C nebulizer temperature and 1.1 standard litres per minute

92 t composition, organic modifier content, and nebulizer temperature on the photoionization efficiency

93 ent flow rate and composition as well as the nebulizer temperatures on the ionization efficiency of r

94 ent flow rate and composition as well as the nebulizer temperatures on the photoionization efficiency

95 w rate, extraction time, acid concentration, nebulizer tip to sample surface gap, and morg/maq ratio.

96 uctively coupled plasma (ICP) torch from the nebulizer tip to the site of analytical measurements.

97 rosol field at distances of 5-30 mm from the nebulizer tip where droplet sizes ranged from 6 to 12 mi

98 imens (i.e., from a nebulizer solution and a nebulizer tube).

99 icrom for a direct injection high efficiency nebulizer used in inductively coupled plasma spectrometr

100 am-negative bacteria generated from home-use nebulizers used by cystic fibrosis (CF) patients may be

101 mass spectrometry (ICPMS) with an ultrasonic nebulizer (USN).

102 A mesh nebulizer was customized to improve IgG 43RCA-G1 deposit

103 the second design, a miniaturized pneumatic nebulizer was fabricated as an integral part of the chip

104 l propylene glycol) using an AeroTech II jet nebulizer was instituted daily for 12 consecutive days f

105 When the nebulizer was operated with O2, greater albuterol delive

106 nebulization chamber and in the conventional nebulizer were brought to make ELSD fully compatible wit

107 on detection limits using the more efficient nebulizer were estimated to be 0.2 ng and 10 ng mL(-1),

108 Sputum cultures for two patients whose nebulizers were contaminated with B. cepacia did not yie

109 Sixty-nine percent of nebulizers were contaminated, and up to 16 different env

110 Various nebulizers were examined and found to be effective in pr

111 a was isolated from 34 patients, none of the nebulizers were positive for the organism.

112 I 75 mg or placebo (three-times daily; eFlow nebulizer) were each followed by a 4-week off-treatment

113 a large-bore DIHEN; and (3) a MicroFlow PFA nebulizer with a PFA Scott-type spray chamber.

114 a large-bore DIHEN; and (3) a PFA microflow nebulizer with a PFA Scott-type spray chamber.

115 s in our laboratory using a glass concentric nebulizer with cyclonic spray chamber arrangement.